DOI: 10.1007/s10096-005-1294-x. Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B

Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B

10.1007/s10096-005-1294-x

Crossref journal-article

Springer Science and Business Media LLC

European Journal of Clinical Microbiology & Infectious Diseases (297)

Bibliography

Bratu, S., Quale, J., Cebular, S., Heddurshetti, R., & Landman, D. (2005). Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B. European Journal of Clinical Microbiology & Infectious Diseases, 24(3), 196â201.

Authors 5

S. Bratu (first)
J. Quale (additional)
S. Cebular (additional)
R. Heddurshetti (additional)
D. Landman (additional)

References 28 Referenced 31

Go ES, Urban C, Burns J et al (1994) Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344:1329?1332 (10.1016/S0140-6736(94)90694-7) / Lancet by ES Go (1994)
Rahal JJ, Urban C, Horn D et al (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233?1237 (10.1001/jama.280.14.1233) / JAMA by JJ Rahal (1998)
Landman D, Quale JM, Mayorga D et al (2002) Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the pre-antibiotic era has returned. Arch Intern Med 162:1515?1520 (10.1001/archinte.162.13.1515) / Arch Intern Med by D Landman (2002)
Duncan IBR (1974) Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother 5:9?15 (10.1128/AAC.5.1.9) / Antimicrob Agents Chemother by IBR Duncan (1974)
National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Document M100-S12. NCCLS, Wayne, PA / Performance standards for antimicrobial susceptibility testing. Document M100-S12 by National Committee for Clinical Laboratory Standards (2002)
Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183?190 (10.1128/JCM.39.1.183-190.2001) / J Clin Microbiol by AC Gales (2001)
National Nosocomial Infections Surveillance System (2002) Data summary from January 1992 to June 2002. Am J Infect Control 30:458?475 (10.1067/mic.2002.130032) / Am J Infect Control by National Nosocomial Infections Surveillance System (2002)
Landman D, Mobarakai NK, Quale JM (1993) Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother 37:1904?1908 (10.1128/AAC.37.9.1904) / Antimicrob Agents Chemother by D Landman (1993)
Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J (2000) Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31:101?106 (10.1086/313902) / Clin Infect Dis by VM Manikal (2000)
Kucers A (1997) Polymyxins. In: Kucers A, Crowe S, Grayson ML, Hoy J (eds) The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs, 5th edn. Butterworth-Heinemann, Oxford, UK, pp 667?675 / The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs by A Kucers (1997)
Kucers A (1997) Azithromycin. In: Kucers A, Crowe S, Grayson ML, Hoy J (eds) The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs, 5th edn. Butterworth-Heinemann, Oxford, UK, pp 653?662 / The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs by A Kucers (1997)
Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J (2001) Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program. Clin Infect Dis 32(Suppl 2):S104?S113 (10.1086/320183) / Clin Infect Dis by AC Gales (2001)
Mutnick AH, Rhomberg PR, Sader HS, Jones RN (2004) Antimicrobial usage and resistance trend relationships from the MYSTIC programme in North America (1999?2001). J Antimicrob Chemother 53:290?296 (10.1093/jac/dkh039) / J Antimicrob Chemother by AH Mutnick (2004)
Radberg G, Nilsson LE, Svensson S (1990) Development of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 34:2142?2147 (10.1128/AAC.34.11.2142) / Antimicrob Agents Chemother by G Radberg (1990)
Aubert G, Pozzetto B, Dorche G (1992) Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. J Antimicrob Chemother 29:307?312 (10.1093/jac/29.3.307) / J Antimicrob Chemother by G Aubert (1992)
Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634?640 (10.1086/338782) / Clin Infect Dis by DM Livermore (2002)
Gilbert DN (2000) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett?s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, PA, pp 307?336 / Mandell, Douglas, and Bennett?s principles and practice of infectious diseases by DN Gilbert (2000)
Stein A, Raoult D (2002) Colistin: an antimicrobial for the 21st century? Clin Infect Dis 35:901?902 (10.1086/342570) / Clin Infect Dis by A Stein (2002)
Levin AS, Barone AA, Penco J, et al (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008?1011 (10.1086/514732) / Clin Infect Dis by AS Levin (1999)
Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D (2003) Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 37:e154?e160 (10.1086/379611) / Clin Infect Dis by PK Linden (2003)
Markou N, Apostolakos H, Koumoudiou C et al (2003) Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 7:R78?R83 (10.1186/cc2358) / Crit Care by N Markou (2003)
Eickhoff T, Finland M (1965) Polymyxin B and colistin: in vitro activity against Pseudomonas aeruginosa. Am J Med Sci 249:172?174 / Am J Med Sci by T Eickhoff (1965)
Pollack M (2000) Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett?s principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, PA, pp 2310?2335 / Mandell, Douglas, and Bennett?s principles and practice of infectious diseases by M Pollack (2000)
Ofek I, Cohen S, Rahmani R, et al (1994) Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother 38:374?377 (10.1128/AAC.38.2.374) / Antimicrob Agents Chemother by I Ofek (1994)
Tateda K, Ishii Y, Matsumoto T et al (1996) Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrob Agents Chemother 40:2271?2275 (10.1128/AAC.40.10.2271) / Antimicrob Agents Chemother by K Tateda (1996)
Molinari G, Guzman A, Pesce A, Schito GC (1993) Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother 31:681?688 (10.1093/jac/31.5.681) / J Antimicrob Chemother by G Molinari (1993)
Tateda K, Comte R, Pechere J, Kohler T, Yamaguchi K, Van Delden C (2001) Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45:1930?1933 (10.1128/AAC.45.6.1930-1933.2001) / Antimicrob Agents Chemother by K Tateda (2001)
Hirakata Y, Kaku M, Tomono K et al (1992) Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. Antimicrob Agents Chemother 36:1198?1203 (10.1128/AAC.36.6.1198) / Antimicrob Agents Chemother by Y Hirakata (1992)

Dates

Type	When
Created	20 years, 5 months ago (March 16, 2005, 4:41 a.m.)
Deposited	6 years, 3 months ago (May 29, 2019, 5:30 a.m.)
Indexed	1 year, 2 months ago (June 10, 2024, 3:14 p.m.)
Issued	20 years, 6 months ago (March 1, 2005)
Published	20 years, 6 months ago (March 1, 2005)
Published Online	20 years, 5 months ago (March 17, 2005)
Published Print	20 years, 6 months ago (March 1, 2005)

Funders 0

None

BibTeX

@article{Bratu_2005, title={Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B}, volume={24}, ISSN={1435-4373}, url={http://dx.doi.org/10.1007/s10096-005-1294-x}, DOI={10.1007/s10096-005-1294-x}, number={3}, journal={European Journal of Clinical Microbiology & Infectious Diseases}, publisher={Springer Science and Business Media LLC}, author={Bratu, S. and Quale, J. and Cebular, S. and Heddurshetti, R. and Landman, D.}, year={2005}, month=mar, pages={196–201} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        6,
        10
      ]
    ],
    "date-time": "2024-06-10T19:14:35Z",
    "timestamp": 1718046875582
  },
  "reference-count": 28,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2005,
            3,
            1
          ]
        ],
        "date-time": "2005-03-01T00:00:00Z",
        "timestamp": 1109635200000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2005,
        3
      ]
    ]
  },
  "DOI": "10.1007/s10096-005-1294-x",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        3,
        16
      ]
    ],
    "date-time": "2005-03-16T09:41:14Z",
    "timestamp": 1110966074000
  },
  "page": "196-201",
  "source": "Crossref",
  "is-referenced-by-count": 31,
  "title": "Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B",
  "prefix": "10.1007",
  "volume": "24",
  "author": [
    {
      "given": "S.",
      "family": "Bratu",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "J.",
      "family": "Quale",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "S.",
      "family": "Cebular",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "R.",
      "family": "Heddurshetti",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "D.",
      "family": "Landman",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "published-online": {
    "date-parts": [
      [
        2005,
        3,
        17
      ]
    ]
  },
  "reference": [
    {
      "key": "CR1",
      "doi-asserted-by": "crossref",
      "first-page": "1329",
      "DOI": "10.1016/S0140-6736(94)90694-7",
      "volume": "344",
      "author": "ES Go",
      "year": "1994",
      "unstructured": "Go ES, Urban C, Burns J et al (1994) Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344:1329?1332",
      "journal-title": "Lancet"
    },
    {
      "key": "CR2",
      "doi-asserted-by": "crossref",
      "first-page": "1233",
      "DOI": "10.1001/jama.280.14.1233",
      "volume": "280",
      "author": "JJ Rahal",
      "year": "1998",
      "unstructured": "Rahal JJ, Urban C, Horn D et al (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233?1237",
      "journal-title": "JAMA"
    },
    {
      "key": "CR3",
      "doi-asserted-by": "crossref",
      "first-page": "1515",
      "DOI": "10.1001/archinte.162.13.1515",
      "volume": "162",
      "author": "D Landman",
      "year": "2002",
      "unstructured": "Landman D, Quale JM, Mayorga D et al (2002) Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the pre-antibiotic era has returned. Arch Intern Med 162:1515?1520",
      "journal-title": "Arch Intern Med"
    },
    {
      "key": "CR4",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "DOI": "10.1128/AAC.5.1.9",
      "volume": "5",
      "author": "IBR Duncan",
      "year": "1974",
      "unstructured": "Duncan IBR (1974) Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother 5:9?15",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "CR5",
      "volume-title": "Performance standards for antimicrobial susceptibility testing. Document M100-S12",
      "author": "National Committee for Clinical Laboratory Standards",
      "year": "2002",
      "unstructured": "National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Document M100-S12. NCCLS, Wayne, PA"
    },
    {
      "key": "CR6",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "DOI": "10.1128/JCM.39.1.183-190.2001",
      "volume": "39",
      "author": "AC Gales",
      "year": "2001",
      "unstructured": "Gales AC, Reis AO, Jones RN (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183?190",
      "journal-title": "J Clin Microbiol"
    },
    {
      "key": "CR7",
      "doi-asserted-by": "crossref",
      "first-page": "458",
      "DOI": "10.1067/mic.2002.130032",
      "volume": "30",
      "author": "National Nosocomial Infections Surveillance System",
      "year": "2002",
      "unstructured": "National Nosocomial Infections Surveillance System (2002) Data summary from January 1992 to June 2002. Am J Infect Control 30:458?475",
      "journal-title": "Am J Infect Control"
    },
    {
      "key": "CR8",
      "doi-asserted-by": "crossref",
      "first-page": "1904",
      "DOI": "10.1128/AAC.37.9.1904",
      "volume": "37",
      "author": "D Landman",
      "year": "1993",
      "unstructured": "Landman D, Mobarakai NK, Quale JM (1993) Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother 37:1904?1908",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "CR9",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.1086/313902",
      "volume": "31",
      "author": "VM Manikal",
      "year": "2000",
      "unstructured": "Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J (2000) Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31:101?106",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "CR10",
      "first-page": "667",
      "volume-title": "The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs",
      "author": "A Kucers",
      "year": "1997",
      "unstructured": "Kucers A (1997) Polymyxins. In: Kucers A, Crowe S, Grayson ML, Hoy J (eds) The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs, 5th edn. Butterworth-Heinemann, Oxford, UK, pp 667?675",
      "edition": "5"
    },
    {
      "key": "CR11",
      "first-page": "653",
      "volume-title": "The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs",
      "author": "A Kucers",
      "year": "1997",
      "unstructured": "Kucers A (1997) Azithromycin. In: Kucers A, Crowe S, Grayson ML, Hoy J (eds) The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs, 5th edn. Butterworth-Heinemann, Oxford, UK, pp 653?662",
      "edition": "5"
    },
    {
      "issue": "Suppl 2",
      "key": "CR12",
      "doi-asserted-by": "crossref",
      "first-page": "S104",
      "DOI": "10.1086/320183",
      "volume": "32",
      "author": "AC Gales",
      "year": "2001",
      "unstructured": "Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J (2001) Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program. Clin Infect Dis 32(Suppl 2):S104?S113",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "CR13",
      "doi-asserted-by": "crossref",
      "first-page": "290",
      "DOI": "10.1093/jac/dkh039",
      "volume": "53",
      "author": "AH Mutnick",
      "year": "2004",
      "unstructured": "Mutnick AH, Rhomberg PR, Sader HS, Jones RN (2004) Antimicrobial usage and resistance trend relationships from the MYSTIC programme in North America (1999?2001). J Antimicrob Chemother 53:290?296",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "CR14",
      "doi-asserted-by": "crossref",
      "first-page": "2142",
      "DOI": "10.1128/AAC.34.11.2142",
      "volume": "34",
      "author": "G Radberg",
      "year": "1990",
      "unstructured": "Radberg G, Nilsson LE, Svensson S (1990) Development of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 34:2142?2147",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "CR15",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "DOI": "10.1093/jac/29.3.307",
      "volume": "29",
      "author": "G Aubert",
      "year": "1992",
      "unstructured": "Aubert G, Pozzetto B, Dorche G (1992) Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy. J Antimicrob Chemother 29:307?312",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "CR16",
      "doi-asserted-by": "crossref",
      "first-page": "634",
      "DOI": "10.1086/338782",
      "volume": "34",
      "author": "DM Livermore",
      "year": "2002",
      "unstructured": "Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634?640",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "CR17",
      "first-page": "307",
      "volume-title": "Mandell, Douglas, and Bennett?s principles and practice of infectious diseases",
      "author": "DN Gilbert",
      "year": "2000",
      "unstructured": "Gilbert DN (2000) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett?s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, PA, pp 307?336"
    },
    {
      "key": "CR18",
      "doi-asserted-by": "crossref",
      "first-page": "901",
      "DOI": "10.1086/342570",
      "volume": "35",
      "author": "A Stein",
      "year": "2002",
      "unstructured": "Stein A, Raoult D (2002) Colistin: an antimicrobial for the 21st century? Clin Infect Dis 35:901?902",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "CR19",
      "doi-asserted-by": "crossref",
      "first-page": "1008",
      "DOI": "10.1086/514732",
      "volume": "28",
      "author": "AS Levin",
      "year": "1999",
      "unstructured": "Levin AS, Barone AA, Penco J, et al (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008?1011",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "CR20",
      "doi-asserted-by": "crossref",
      "first-page": "e154",
      "DOI": "10.1086/379611",
      "volume": "37",
      "author": "PK Linden",
      "year": "2003",
      "unstructured": "Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D (2003) Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 37:e154?e160",
      "journal-title": "Clin Infect Dis"
    },
    {
      "key": "CR21",
      "doi-asserted-by": "crossref",
      "first-page": "R78",
      "DOI": "10.1186/cc2358",
      "volume": "7",
      "author": "N Markou",
      "year": "2003",
      "unstructured": "Markou N, Apostolakos H, Koumoudiou C et al (2003) Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit Care 7:R78?R83",
      "journal-title": "Crit Care"
    },
    {
      "key": "CR22",
      "first-page": "172",
      "volume": "249",
      "author": "T Eickhoff",
      "year": "1965",
      "unstructured": "Eickhoff T, Finland M (1965) Polymyxin B and colistin: in vitro activity against Pseudomonas aeruginosa. Am J Med Sci 249:172?174",
      "journal-title": "Am J Med Sci"
    },
    {
      "key": "CR23",
      "first-page": "2310",
      "volume-title": "Mandell, Douglas, and Bennett?s principles and practice of infectious diseases",
      "author": "M Pollack",
      "year": "2000",
      "unstructured": "Pollack M (2000) Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett?s principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, PA, pp 2310?2335",
      "edition": "5"
    },
    {
      "key": "CR24",
      "doi-asserted-by": "crossref",
      "first-page": "374",
      "DOI": "10.1128/AAC.38.2.374",
      "volume": "38",
      "author": "I Ofek",
      "year": "1994",
      "unstructured": "Ofek I, Cohen S, Rahmani R, et al (1994) Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother 38:374?377",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "CR25",
      "doi-asserted-by": "crossref",
      "first-page": "2271",
      "DOI": "10.1128/AAC.40.10.2271",
      "volume": "40",
      "author": "K Tateda",
      "year": "1996",
      "unstructured": "Tateda K, Ishii Y, Matsumoto T et al (1996) Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrob Agents Chemother 40:2271?2275",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "CR26",
      "doi-asserted-by": "crossref",
      "first-page": "681",
      "DOI": "10.1093/jac/31.5.681",
      "volume": "31",
      "author": "G Molinari",
      "year": "1993",
      "unstructured": "Molinari G, Guzman A, Pesce A, Schito GC (1993) Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother 31:681?688",
      "journal-title": "J Antimicrob Chemother"
    },
    {
      "key": "CR27",
      "doi-asserted-by": "crossref",
      "first-page": "1930",
      "DOI": "10.1128/AAC.45.6.1930-1933.2001",
      "volume": "45",
      "author": "K Tateda",
      "year": "2001",
      "unstructured": "Tateda K, Comte R, Pechere J, Kohler T, Yamaguchi K, Van Delden C (2001) Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45:1930?1933",
      "journal-title": "Antimicrob Agents Chemother"
    },
    {
      "key": "CR28",
      "doi-asserted-by": "crossref",
      "first-page": "1198",
      "DOI": "10.1128/AAC.36.6.1198",
      "volume": "36",
      "author": "Y Hirakata",
      "year": "1992",
      "unstructured": "Hirakata Y, Kaku M, Tomono K et al (1992) Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. Antimicrob Agents Chemother 36:1198?1203",
      "journal-title": "Antimicrob Agents Chemother"
    }
  ],
  "container-title": "European Journal of Clinical Microbiology &amp; Infectious Diseases",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10096-005-1294-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10096-005-1294-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10096-005-1294-x",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        29
      ]
    ],
    "date-time": "2019-05-29T09:30:20Z",
    "timestamp": 1559122220000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10096-005-1294-x"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2005,
        3
      ]
    ]
  },
  "references-count": 28,
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2005,
          3
        ]
      ]
    }
  },
  "alternative-id": [
    "1294"
  ],
  "URL": "http://dx.doi.org/10.1007/s10096-005-1294-x",
  "relation": {},
  "ISSN": [
    "0934-9723",
    "1435-4373"
  ],
  "subject": [],
  "container-title-short": "Eur J Clin Microbiol Infect Dis",
  "published": {
    "date-parts": [
      [
        2005,
        3
      ]
    ]
  }
}